Home > Publications database > Structural characterization of the microbial enzyme urocanate reductase mediating imidazole propionate production > print

001     472478
005     20250724175827.0
024 7 _ |a 10.1038/s41467-021-21548-y
|2 doi
024 7 _ |a 10.3204/PUBDB-2021-05031
|2 datacite_doi
024 7 _ |a altmetric:101061627
|2 altmetric
024 7 _ |a pmid:33649331
|2 pmid
024 7 _ |a WOS:000626168500003
|2 WOS
024 7 _ |a openalex:W3133805846
|2 openalex
037 _ _ |a PUBDB-2021-05031
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Venskutonytė, Raminta
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Structural characterization of the microbial enzyme urocanate reductase mediating imidazole propionate production
260 _ _ |a [London]
|c 2021
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1638783549_4312
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The human microbiome can produce metabolites that modulate insulin signaling. Type 2 diabetes patients have increased circulating concentrations of the microbially produced histidine metabolite, imidazole propionate (ImP) and administration of ImP in mice resulted in impaired glucose tolerance. Interestingly, the fecal microbiota of the patients had increased capacity to produce ImP, which is mediated by the bacterial enzyme urocanate reductase (UrdA). Here, we describe the X-ray structures of the ligand-binding domains of UrdA in four different states, representing the structural transitions along the catalytic reaction pathway of this unexplored enzyme linked to disease in humans. The structures in combination with functional data provide key insights into the mechanism of action of UrdA that open new possibilities for drug development strategies targeting type 2 diabetes.
536 _ _ |a 6G3 - PETRA III (DESY) (POF4-6G3)
|0 G:(DE-HGF)POF4-6G3
|c POF4-6G3
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de
693 _ _ |a PETRA III
|f PETRA Beamline P13
|1 EXP:(DE-H253)PETRAIII-20150101
|0 EXP:(DE-H253)P-P13-20150101
|6 EXP:(DE-H253)P-P13-20150101
|x 0
700 1 _ |a Koh, Ara
|b 1
700 1 _ |a Stenström, Olof
|b 2
700 1 _ |a Khan, Muhammad Tanweer
|b 3
700 1 _ |a Lundqvist, Annika
|b 4
700 1 _ |a Akke, Mikael
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Bäckhed, Fredrik
|0 0000-0002-4871-8818
|b 6
700 1 _ |a Lindkvist-Petersson, Karin
|0 0000-0002-5209-3160
|b 7
|e Corresponding author
773 _ _ |a 10.1038/s41467-021-21548-y
|g Vol. 12, no. 1, p. 1347
|0 PERI:(DE-600)2553671-0
|n 1
|p 1347
|t Nature Communications
|v 12
|y 2021
|x 2041-1723
856 4 _ |u https://www.nature.com/articles/s41467-021-21548-y
856 4 _ |u https://bib-pubdb1.desy.de/record/472478/files/Structural%20characterization%20of%20the%20microbial%20enzyme%20urocanate%20reductase%20mediating%20imidazole%20propionate%20production.pdf
|y OpenAccess
856 4 _ |u https://bib-pubdb1.desy.de/record/472478/files/Structural%20characterization%20of%20the%20microbial%20enzyme%20urocanate%20reductase%20mediating%20imidazole%20propionate%20production.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:bib-pubdb1.desy.de:472478
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Großgeräte: Materie
|1 G:(DE-HGF)POF4-6G0
|0 G:(DE-HGF)POF4-6G3
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-600
|4 G:(DE-HGF)POF
|v PETRA III (DESY)
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-02
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2021-02-02
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-02-02
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2019
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-02
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NAT COMMUN : 2019
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-02-02
920 1 _ |0 I:(DE-H253)EMBL-User-20120814
|k EMBL-User
|l EMBL-User
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-H253)EMBL-User-20120814
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21